Clinical Trial Update: INSPIRIS China PMCF Study

View source ↗

Summary

Edwards Lifesciences' INSPIRIS China PMCF Study is a post-market clinical follow-up for the INSPIRIS aortic valve prosthesis, and the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• INSPIRIS RESILIA aortic valve prosthesis (aortic valve prosthesis)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Valve Replacement | Status: ACTIVE_NOT_RECRUITING